SEC Filings | Cullinan Therapeutics, Inc.

Filing date	Form	Description	View
March 2, 2022	3	Initial filing by director officer or owner of more than ten percent.	0000899243-22-008726.pdf 0000899243-22-008726.rtf 0000899243-22-008726.xls View HTML
March 2, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-008729.pdf 0000899243-22-008729.rtf 0000899243-22-008729.xls View HTML
March 2, 2022	3	Initial filing by director officer or owner of more than ten percent.	0000899243-22-008727.pdf 0000899243-22-008727.rtf 0000899243-22-008727.xls View HTML
February 15, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-006413.pdf 0000899243-22-006413.rtf 0000899243-22-006413.xls View HTML
February 15, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-006412.pdf 0000899243-22-006412.rtf 0000899243-22-006412.xls View HTML
February 15, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-006419.pdf 0000899243-22-006419.rtf 0000899243-22-006419.xls View HTML
February 15, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-006417.pdf 0000899243-22-006417.rtf 0000899243-22-006417.xls View HTML
February 15, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-006421.pdf 0000899243-22-006421.rtf 0000899243-22-006421.xls View HTML
February 15, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-006427.pdf 0000899243-22-006427.rtf 0000899243-22-006427.xls View HTML
February 14, 2022	SC 13G/A	An amendment to the SC 13G filing	0000921895-22-000523.pdf 0000921895-22-000523.rtf 0000921895-22-000523.xls View HTML

Data provided by Kaleidoscope.